MONTREAL,
Sept. 11, 2013 /PRNewswire/ - Global
Biotech Corp. (OTC-GBIQ) (the "Company") is pleased to announce
that it has finalized its acquisition of all the intellectual
property, process know-how and methodology for the production of
Athanol, a green- technology ethanol fuel alternative, from
Purthanol International as of today. Further, the Company has
acquired purchase orders of $28.5 million
USD for the purchase of ethanol or Athanol from Purthanol
International, delivery within the ensuing 12 months. This
acquisition was consummated for treasury shares from Global valued
at $700,000 USD.
About Global Biotech Corp.
Global is a publicly traded company dedicated to
investigating and developing natural products for the
neutraceutical, pharmaceutical and cosmeceutical industries. It has
recently changed its orientation to focus on green-technology fuel
production with its acquisition of the Purthanol extraction
process. Visit www.globalbiotechcorp.com for more information.
About Purthanol International
Purthanol International is a company focused on
efficient and ecologically sound energy production methodologies.
As of Q2, Purthanol International began active work on its
Purthanol fuel production, to fulfill purchase orders on hand.
CAUTIONARY STATEMENT
Other than statements of historical fact,
included herein, all statements are forward-looking and involve
risks and uncertainties. There can be no assurance that such
statements will prove to be accurate, and actual results may differ
materially from Global's expectations and filings made with the
securities regulators. The Company does not assume any obligation
to update or revise its forward-looking statements. No stock
exchange, securities commission or other regulatory authority has
approved or disapproved this information.
SOURCE Global Biotech Corp
